相关实验视频

Updated: Aug 10, 2026

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
09:24

3-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer

Published on: September 13, 2018

9.1K

基于路径的癌症转录组解读了膀癌症分类中的高分辨率内在异质性

Zhan Wang1, Zhaokai Zhou2, Shuai Yang1

  • 1Department of Urology, The First Affiliated Hospital of Zhengzhou University, Henan, 450052, China.

Journal of translational medicine
|June 17, 2025
PubMed
概括

这项研究揭示了基于内在基因表达的四种膀癌 (BLCA) 亚型,提供了新的预后和治疗见解. 针对REXO2可能通过解决BLCA中的代谢障碍来改善结果.

关键词:
膀癌是一种癌症.免疫微环境是一个微环境.本质的异质性 本质的异质性代谢障碍是一种代谢障碍.分子子类型 分子子类型一个单细胞RNA-seqq.

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Culture of Bladder Cancer Organoids as Precision Medicine Tools08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

4.9K

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...